13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001716476
Total reported value
$20.3M
$20.3M
10 檔
69.1%
According to the latest 13F quarterly dataset, Vazirani Asset Management LLC managed an equity portfolio of $20.3M at the end of Q4 2025, spanning 10 distinct U.S. exchange-listed positions.
In Q4 2025, Vazirani Asset Management LLC adopted a defensive or profit-taking posture, trimming 1 positions and completely liquidating 11 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NSC | Norfolk Southern CORP | Stock-Industrials | 26.29% | +1.12% | +20.00% | |
| 2 | DAY | Dayforce Inc | Stock-Other | 20.99% | — | — | |
| 3 | EXK | Exact Sciences CORP | Stock-Materials | 15.41% | — | — | |
| 4 | FYBR | Frontier Communications Pare | Stock-Other | 11.55% | — | -33.33% | |
| 5 | 8QR | Confluent Inc-class A | Stock-Other | 11.00% | — | — | |
| 6 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 5.25% | +3.24% | — | |
| 7 | CDTX | Cidara Therapeutics Inc | Stock-Other | 3.35% | — | — | |
| 8 | AM6 | Amicus Therapeutics Inc | Stock-Other | 2.16% | — | — | |
| 9 | ✓ | Realogy Hldgs CORP Com | Stock-Other | 2.15% | — | — | |
| 10 | 2KZ0 | Kezar Life Sciences Inc | Stock-Other | 1.85% | -0.38% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NSC | Norfolk Southern CORP | +12.9% | +20.00% | Add |
| 2 | FYBR | Frontier Communications Pare | +1.5% | -33.33% | Trim |
| 3 | VRNA | Verona Pharma PLC - Adr | — | EXIT | Sold out |
| 4 | 07WA | Mr Cooper Group Inc | — | EXIT | Sold out |
| 5 | DAY | Dayforce Inc | — | NEW | New buy |
| 6 | EXK | Exact Sciences CORP | — | NEW | New buy |
| 7 | EA | Electronic Arts Inc | — | EXIT | Sold out |
| 8 | S9Q | Spirit Aerosystems Hold-cl A | — | EXIT | Sold out |
| 9 | AEBA | Allete Inc | — | EXIT | Sold out |
| 10 | 8QR | Confluent Inc-class A | — | NEW | New buy |
| 11 | OMC | Omnicom Group | — | EXIT | Sold out |
| 12 | COMP | Compass Inc - Class A | — | EXIT | Sold out |
| 13 | WBD | Warner Bros Discovery Inc | — | NEW | New buy |
| 14 | HN9 | Hanesbrands Inc | — | EXIT | Sold out |
| 15 | CDTX | Cidara Therapeutics Inc | — | NEW | New buy |
| 16 | PLYM | Plymouth Industrial Reit Inc | — | EXIT | Sold out |
| 17 | AM6 | Amicus Therapeutics Inc | — | NEW | New buy |
| 18 | ✓ | Realogy Hldgs CORP Com | — | NEW | New buy |
| 19 | 2KZ0 | Kezar Life Sciences Inc | — | NEW | New buy |
| 20 | SU6 | Surmodics Inc | — | EXIT | Sold out |
| 21 | CCRN | Cross Country Healthcare Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Vazirani Asset Management LLC reported a total U.S. public equity portfolio value of $20.3M across 10 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NSC, DAY, EXK) accounted for 69.1% of total reported equity market value during Q4 2025.
Top New Position Initiated
DAY
市值: $3.5M
Top Position Liquidated / Trimmed
VRNA
前期市值: $6.4M
During Q4 2025, Vazirani Asset Management LLC's top holdings by market value included NSC (26.3%)、DAY (21.0%)、EXK (15.4%). The largest single position, NSC, represented 26.3% of total portfolio value.
In Q4 2025, Vazirani Asset Management LLC made 21 total portfolio adjustments, initiating 8 new buys, adding to 1 positions, trimming 1 holdings, and fully liquidating 11 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.